Bing

SEARCH HISTORY

“A spinoff remains a valuable option.” But even if left intact, Pfizer remains undervalued. Neither earnings forecasts nor the current stock price reflect the new markets, synergies and accretion promised by the Hospira acquisition, nor a research ...
Barron's · ByJohanna Bennett · 4/21/2015
PureTech is aiming to join a cluster of companies on the London Stock Exchange whose business model involves ... with partners including big groups such as Johnson & Johnson, Pfizer and Google. The IPO will …
Financial Times · 3 hours ago
Pfizer's deal to buy Hospira for $15B sends the Illinois drugmaker's stock soaring. Analyst “would be surprised” if Hospira CEO Michael Ball stays on after deal with Pfizer. Pharmaceutical giant Pfizer has agreed to buy Lake Forest-based Hospira for ...
Chicago Tribune · 2/5/2015
More from Bing News
10.09.2013 Pfizer halten Jefferies & Company Inc. 12.07.2013 Pfizer halten Jefferies & Company Inc. 25.06.2013 Pfizer halten Independent Research GmbH 14.06.2013 Pfizer halten Independent Research GmbH 27.11.2012 Pfizer verkaufen Hamburger …
Finanzen · 2/10/2015
Pfizer (PFE) Stock Offer, Spinoff Report Sees Fundamental Break-Up Post Zoetis (ZTS); Remember Bristol Myers & Mead Johnson? 400m shares are due to hit the market and today’s the last day for tendering Pfizer (PFE) common shares in exchange …
Reuters · 6/19/2013
But the price of Pfizer stock dropped in Jan. 26, 2009 after the drug maker revealed plans to pay $2.3 billion to resolve criminal and civil allegations that these drugs were marketed illegally. The disclosure, however, was nearly drowned out that same day ...
The Wall Street Journal · 1/27/2015
Now, Pfizer is looking toward Hospira to increase its earnings per share. Pfizer stock was up nearly 3 percent on Thursday on the news of the deal. Pfizer said the deal should result in $800 million in annual cost savings by 2018, and is expected to close ...
Deal Book · 2/5/2015
Big pharma Pfizer (PFE) was down 2.5% in morning trading on the stock market today after its breast-cancer drug palbociclib did well in trials but fell a bit short of sky-high expectations. At the American Association for Cancer Research meeting on Sunday ...
Investors Business Daily · ByAmy Reeves · 4/7/2014
According to this recent filing, Fisher’s largest stock positions are Apple Inc. (NASDAQ:AAPL), Pfizer Inc. (NYSE ... This is a FREE report from Insider Monkey. Credit Card is NOT required.
INSIDER MONKEY · 5/2/2015
Earlier this month, Pfizer (NYSE:PFE) and Merck KGaA struck a deal for the development of the latter’s investigational anti-PD1 drug. Under the terms of the deal, Pfizer will make an upfront payment of $850 million, with additional payment of $2 billion ...
Trefis · 11/24/2014